| Code | CSB-RA706511MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody APL-9796, specifically targeting SLC39A12 (solute carrier family 39 member 12), also known as ZIP12. SLC39A12 functions as a zinc transporter protein that facilitates the cellular uptake of zinc ions across the plasma membrane, playing a critical role in maintaining zinc homeostasis within cells. This transporter is particularly relevant in metabolic regulation and has been implicated in various pathological conditions including obesity, insulin resistance, type 2 diabetes, and Alzheimer's disease. Aberrant expression of SLC39A12 has also been associated with certain cancers and neurodegenerative disorders, where altered zinc metabolism contributes to disease progression.
As a biosimilar to APL-9796, this antibody provides researchers with a reliable tool for investigating SLC39A12 expression patterns, cellular localization, and functional roles in various biological contexts. It serves as a valuable reagent for studies examining zinc homeostasis mechanisms, metabolic disease pathways, and the therapeutic potential of targeting zinc transporters in human disease models.
There are currently no reviews for this product.